JPH1045530A - Emulsion system containing small amount of ethoxylated emulsifier - Google Patents
Emulsion system containing small amount of ethoxylated emulsifierInfo
- Publication number
- JPH1045530A JPH1045530A JP9131114A JP13111497A JPH1045530A JP H1045530 A JPH1045530 A JP H1045530A JP 9131114 A JP9131114 A JP 9131114A JP 13111497 A JP13111497 A JP 13111497A JP H1045530 A JPH1045530 A JP H1045530A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- fatty acid
- composition
- group
- ethoxylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003995 emulsifying agent Substances 0.000 title abstract description 8
- 239000000839 emulsion Substances 0.000 title abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 59
- 239000000194 fatty acid Substances 0.000 claims abstract description 25
- 239000002537 cosmetic Substances 0.000 claims abstract description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 19
- 229930195729 fatty acid Natural products 0.000 claims abstract description 19
- 230000002087 whitening effect Effects 0.000 claims abstract description 15
- 150000001298 alcohols Chemical class 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 8
- 230000002708 enhancing effect Effects 0.000 claims abstract description 5
- 150000002334 glycols Chemical class 0.000 claims abstract description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 13
- 150000004665 fatty acids Chemical class 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 239000012875 nonionic emulsifier Substances 0.000 claims description 7
- 210000002826 placenta Anatomy 0.000 claims description 7
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 2
- 229940108325 retinyl palmitate Drugs 0.000 claims description 2
- 239000011769 retinyl palmitate Substances 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 2
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 7
- 239000003792 electrolyte Substances 0.000 abstract description 5
- 239000008406 cosmetic ingredient Substances 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 230000003169 placental effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 polydimethylsiloxanes Polymers 0.000 description 23
- 239000000463 material Substances 0.000 description 11
- 239000003755 preservative agent Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 8
- 239000003974 emollient agent Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- NYQLUARHYJAQNS-YCHQMNKZSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxy-2-methylhexanamide Chemical compound NC(=O)[C@@](O)(C)[C@@H](O)[C@H](O)[C@H](O)CO NYQLUARHYJAQNS-YCHQMNKZSA-N 0.000 description 1
- SNPLKNRPJHDVJA-SSDOTTSWSA-N (2s)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutanamide Chemical group OCC(C)(C)[C@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-SSDOTTSWSA-N 0.000 description 1
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- JQJSFAJISYZPER-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(2,3-dihydro-1h-inden-5-ylsulfonyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NS(=O)(=O)C1=CC=C(CCC2)C2=C1 JQJSFAJISYZPER-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical class CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical group CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- XTQUSEDRZLDHRC-UHFFFAOYSA-N 3-octadecanoyloxybutyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCCCCCCCCCC XTQUSEDRZLDHRC-UHFFFAOYSA-N 0.000 description 1
- NZXZINXFUSKTPH-UHFFFAOYSA-N 4-[4-(4-butylcyclohexyl)cyclohexyl]-1,2-difluorobenzene Chemical compound C1CC(CCCC)CCC1C1CCC(C=2C=C(F)C(F)=CC=2)CC1 NZXZINXFUSKTPH-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- ZWSNUPOSLDAWJS-QNDFHXLGSA-N 6,7-dihydroxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2coc3cc(O)c(O)cc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O ZWSNUPOSLDAWJS-QNDFHXLGSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- CMCJFUXWBBHIIL-UHFFFAOYSA-N Propylene glycol stearate Chemical class CC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CMCJFUXWBBHIIL-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- FRGAIZLZPOROJH-BKIJVIAGSA-N [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-hydroxy-3-[2-hydroxy-3-(2-hydroxy-3-octadecanoyloxypropoxy)propoxy]propoxy]oxan-2-yl]methyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COCC(O)CO[C@H]1O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@H]1O FRGAIZLZPOROJH-BKIJVIAGSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- NZIKRHKSEITLPS-UHFFFAOYSA-N butane-1,3-diol;octadecanoic acid Chemical compound CC(O)CCO.CCCCCCCCCCCCCCCCCC(O)=O NZIKRHKSEITLPS-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical class CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ORPJZHOKKGOIGN-KNRYUCGFSA-N octadecanoic acid (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O ORPJZHOKKGOIGN-KNRYUCGFSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- 229940048862 octyldodecyl neopentanoate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、化粧品組成物、特
に皮膚のホワイトニング効果を高めるための化粧品組成
物のためのエトキシル化乳化剤を比較的少量含む乳化系
に関する。FIELD OF THE INVENTION The present invention relates to emulsifying systems containing relatively small amounts of ethoxylated emulsifiers for cosmetic compositions, in particular cosmetic compositions for enhancing the skin whitening effect.
【0002】[0002]
【従来の技術】皮膚に現れるそばかすなどのシミの除去
のため、また皮膚全体のホワイトニング効果を示すため
に、様々なホワイトニング化粧品が記載されてきた。最
近の製剤にはホワイトニング強化活性成分としてプラセ
ンタエキス成分を単独またはその他の薬剤、例えばほん
の一部であるが、コウジ酸(サンショー製薬KKの米国
特許第4,696,813号)、イソフラボングリコシ
ド成分(JP−7−157,494号)およびアスコル
ビン酸(JP−4−041,409号、1992年)等
と組合わせて使用されている。2. Description of the Related Art Various whitening cosmetics have been described for removing freckles and other stains appearing on the skin and for showing the whitening effect of the entire skin. Recent formulations include the placenta extract component alone or as another agent, such as a small portion, as a whitening enhancing active ingredient, such as kojic acid (US Pat. No. 4,696,813 to Sansho Pharmaceutical KK), an isoflavone glycoside component. (JP-7-157,494) and ascorbic acid (JP-4-041,409, 1992).
【0003】しかしながらこれらのホワイトニング剤に
ほかの化粧品成分、例えば水溶性ビタミンが配合された
場合、高レベルの電解質が組成物中に形成される。製品
を安定化させ、かつ、この乳化組成物が皮膚に塗布され
た際、心地よく美学上満足するものであり、マイルドで
良い感触が得られる皮膚軟化剤として作用させるため
に、製剤に乳化剤が添加される。低pHの乳化剤系は、
高い電解質環境では不安定化に対して特に敏感である。
製品は水溶性相と水不溶性相とに分離する傾向がある。[0003] However, when other cosmetic ingredients such as water-soluble vitamins are incorporated into these whitening agents, high levels of electrolytes are formed in the composition. An emulsifier is added to the formulation to stabilize the product and to act as an emollient that, when applied to the skin, is pleasant and aesthetically pleasing when applied to the skin and provides a mild and good feel. Is done. Low pH emulsifier systems are:
It is particularly sensitive to instability in high electrolyte environments.
The product tends to separate into a water soluble phase and a water insoluble phase.
【0004】先行技術の製剤組成物において、処方者
は、製品を安定させるため液体油相で液晶が形成するよ
うに乳化剤としてエトキシル化物質を用いてきた。エト
キシル化乳化剤は優れた作用をするが、合成から生じる
ものであり、商業的規模では取り扱いに注意を要する。
最近、植物由来で、毒性が低くエコロジー効果のある乳
化物質が開発された。[0004] In prior art pharmaceutical compositions, formulators have used ethoxylated materials as emulsifiers to form liquid crystals in the liquid oil phase to stabilize the product. Ethoxylated emulsifiers work well, but result from synthesis and require careful handling on a commercial scale.
Recently, emulsifying substances of plant origin and having low toxicity and ecological effects have been developed.
【0005】本発明のホワイトニング化粧品組成物のよ
うな適用のためには、商業生産することができ、安定か
つ美学上満足する製品を提供する乳化系が依然として望
まれている。[0005] For applications such as the whitening cosmetic compositions of the present invention, there remains a need for emulsifying systems that can be produced commercially and provide stable and aesthetically pleasing products.
【0006】[0006]
【発明が解決しようとする課題】したがって本発明の目
的は、化粧品組成物、特に消費者にとって美学上満足し
かつマイルドな、皮膚のホワイトニングに有用な組成物
のための乳化系を提供することである。SUMMARY OF THE INVENTION It is therefore an object of the present invention to provide an emulsifying system for cosmetic compositions, in particular compositions which are aesthetically pleasing and mild to consumers and are useful for skin whitening. is there.
【0007】本発明のもう1つの目的は、貯蔵中に電解
質として作用する化粧品成分の存在下においても安定な
状態を保つ化粧品組成物のための乳化系を提供すること
である。It is another object of the present invention to provide an emulsifying system for a cosmetic composition that remains stable in the presence of cosmetic ingredients that act as electrolytes during storage.
【0008】本発明のもう1つの目的は、低pHで効果
のある化粧品組成物のための乳化系を提供することであ
る。[0008] Another object of the present invention is to provide an emulsifying system for cosmetic compositions that are effective at low pH.
【0009】これらおよびその他の目的については、以
下の詳細な説明および実施例においてさらに明らかにな
るであろう。[0009] These and other objects will become more apparent in the following detailed description and examples.
【0010】[0010]
【課題を解決するための手段】皮膚に対するホワイトニ
ング効果を高めるために有用な化粧品組成物が提供され
る。この組成物は、 (a)(i)1〜20のEOを有するC12〜C20脂肪酸
ポリエチレングリコールエステルからなる群から選ばれ
るエトキシル化アルコール、および(ii)実質的にエ
トキシル化アルコールを含まない、グルコースをベース
とした非イオン性乳化剤、からなる群から選ばれる乳化
系約1〜約10重量%; (b)プラセンタエキス約0.5〜約10重量%;及び (c)化粧品として許容し得るキャリヤー1〜99重量
%、を含む。SUMMARY OF THE INVENTION A cosmetic composition useful for enhancing the whitening effect on the skin is provided. The composition is free of (a) (i) ethoxylated alcohols selected from the group consisting of C 12 -C 20 fatty acid polyethylene glycol esters having from 1 to 20 of EO, and (ii) substantially the ethoxylated alcohol About 1 to about 10% by weight of an emulsifying system selected from the group consisting of: a glucose-based nonionic emulsifier; (b) about 0.5 to about 10% by weight of a placenta extract; and (c) cosmetically acceptable. 1 to 99% by weight of the resulting carrier.
【0011】この乳化系は、比較的少量のエトキシル化
物質をベースとしており、安定かつ美学上満足するホワ
イトニング組成物を提供するために、効果的に処方され
ている。The emulsifying system is based on a relatively small amount of ethoxylated material and is effectively formulated to provide a stable and aesthetically pleasing whitening composition.
【0012】本発明による組成物の乳化系は特に約pH
6.8〜pH1、より好ましくは6〜3で有用である。
この組成物はまた、ホワイトニング剤、例えばプラセン
タエキスおよび水溶性ビタミンをも含有する。[0012] The emulsifying system of the composition according to the invention is in particular at about pH
It is useful at 6.8 to pH 1, more preferably 6 to 3.
The composition also contains whitening agents such as placenta extract and water-soluble vitamins.
【0013】本発明の化粧品組成物は、主として、ロー
ション、クリーム、乳液、パック剤等の皮膚用化粧品と
して適用できる。本発明の乳化系はホワイトニング剤と
組合わされて調製され、この混合物は従来から化粧品に
従来用いられているベースに組み込まれる。The cosmetic composition of the present invention can be applied mainly as a cosmetic for skin such as lotions, creams, emulsions, packs and the like. The emulsifying system of the present invention is prepared in combination with a whitening agent, and this mixture is incorporated into a base conventionally used in cosmetics.
【0014】本発明の最適な乳化系は2つの成分から成
る。すなわち、比較的少量のエトキシル化アルコール
と、グルコースをベースとした非イオン性乳化剤物質で
ある。The optimal emulsification system of the present invention consists of two components. That is, a relatively small amount of ethoxylated alcohol and a nonionic emulsifier material based on glucose.
【0015】第一の不可欠要素は、1〜20のEO、好
ましくは1〜10のEOを有する、C12〜C20脂肪酸の
ポリエチレングリコールエステルである。このエステル
は、Vevy社からXalifin(R)という商標名の
商品として入手できる。この物質は約0.2〜約5重量
%、好ましくは約0.5〜約3重量%、最も好ましくは
約0.8〜約2重量%という、比較的少量の範囲におい
て使用される。The first essential element is a polyethylene glycol ester of a C 12 -C 20 fatty acid having an EO of 1 to 20, preferably 1 to 10. This ester is available as a product of the trade name Xalifin (R) from Vevy company. This material is used in a relatively small range of about 0.2 to about 5% by weight, preferably about 0.5 to about 3% by weight, most preferably about 0.8 to about 2% by weight.
【0016】乳化系の第二の不可欠要素は、好ましくは
植物由来のグルコースをベースとした非イオン性乳化剤
である。この乳化剤物質は、実質的にエトキシル化基を
含まない。脂肪酸鎖は、約C7〜C24、好ましくは約C
10〜C18の鎖結合を有するグルコースベース物質からの
側鎖である。好ましい物質は、ポリグリセリル−3メト
ールグルコースジステアレートであり、バージニア州の
Goldschmidt Chemical Corp
orationから、Tegocare 450(R)と
して販売されている。The second essential element of the emulsification system is a nonionic emulsifier, preferably based on glucose from plants. The emulsifier material is substantially free of ethoxylated groups. Fatty chains from about C 7 -C 24, preferably about C
Side chains from glucose-based materials with 10- C18 chain bonds. A preferred material is polyglyceryl-3methol glucose distearate, Goldschmidt Chemical Corp., Virginia.
available from Oration as Tegocare 450 (R) .
【0017】乳化系の2つの不可欠要素の割合は、約
1.5:1〜約5:1、好ましくは2:1〜約3:1で
あろう。The ratio of the two essential components of the emulsifying system will be from about 1.5: 1 to about 5: 1, preferably from 2: 1 to about 3: 1.
【0018】本発明において使用されるプラセンタエキ
スは、米国特許第4,696,813号に記載されてい
る方法のような従来からこの分野で用いられているあら
ゆる方法で得られるホワイトニング剤を含む。プラセン
タエキスは、この組成物中に約0.5〜約10重量%、
好ましくは1〜約5重量%、最も好ましくは約2〜約5
重量%の量で存在すべきである。The placenta extract used in the present invention includes a whitening agent obtained by any method conventionally used in this field, such as the method described in US Pat. No. 4,696,813. Placenta extract comprises about 0.5 to about 10% by weight of the composition;
Preferably from 1 to about 5% by weight, most preferably from about 2 to about 5%
It should be present in a weight percent amount.
【0019】本発明においては、様々な増粘剤も存在す
る。好ましくは重合化グルコースである菌核(scleroti
um)ゴム(CTFA名)が組み込まれる。このカプセル
状β−D−グルカンは、カーボン源としてのグルコース
またはスクロース、および鉱油が補われた複合窒素源を
含む媒質中で成長した様々な菌類から産生できる。Sc
lerotium Glucincumの場合は概算で
重合度が約100のグルカンが得られ、Sclerot
ium Rolfsii菌株からは重合度が約800の
グルカンが得られる。商品としては、 Sclerot
ium Rolfsiiに由来する菌核ゴムが、フラン
スのAlban Muller/TriK社からAmi
gel(R)という商標名で入手できる。この物質の量
は、約0.05〜約1重量%、好ましくは約0.01〜
約0.5重量%、最も好ましくは約0.05〜0.3重
量%である。Various thickeners are also present in the present invention. Scleroti, preferably polymerized glucose
um) Rubber (CTFA name) is incorporated. This encapsulated β-D-glucan can be produced from a variety of fungi grown in media containing glucose or sucrose as a carbon source, and a complex nitrogen source supplemented with mineral oil. Sc
In the case of lerotium Glucincum, glucans having a degree of polymerization of about 100 are roughly obtained.
Glucan having a degree of polymerization of about 800 can be obtained from the ium Rolfsiii strain. Products include Scrollrot
spore rubber derived from ium Rolfsii was purchased from Alban Muller / TriK of France as an Ami
Available under the trade name gel (R) . The amount of this substance may range from about 0.05 to about 1% by weight, preferably from about 0.01 to
It is about 0.5% by weight, most preferably about 0.05-0.3% by weight.
【0020】本発明の組成物は水相を含んでいてもよ
く、あるいは完全に水性であってもよい。有利には、こ
のような水性系のpHは、約pH8.0〜1.0、好ま
しくは約6.8〜約4、最も好ましくは約5.5〜3で
ある。The compositions of the present invention may include an aqueous phase, or may be completely aqueous. Advantageously, the pH of such aqueous systems is between about pH 8.0 and 1.0, preferably between about 6.8 and about 4, most preferably between about 5.5 and 3.
【0021】電解質として作用する水溶性ビタミンも本
発明に組み込んでよい。[水溶性]という用語は、少な
くとも0.1重量%、好ましくは少なくとも1重量%、
最も好ましくは少なくとも5重量%、水に溶解性がある
物質を意味する。水溶性ビタミンの例としては、ナイア
シン、ビタミンB2、ビタミンB6、ビタミンC、および
ビオチンが挙げられる。組成物中のビタミンの総量は、
約0.001〜約1重量%、好ましくは約0.01〜約
0.6重量%、最も好ましくは約0.1〜0.5重量%
である。[0021] Water soluble vitamins that act as electrolytes may also be incorporated into the present invention. The term [water soluble] means at least 0.1% by weight, preferably at least 1% by weight,
Most preferably at least 5% by weight means a substance which is soluble in water. Examples of water-soluble vitamins, niacin, vitamin B 2, vitamin B 6, vitamin C, and include biotin. The total amount of vitamins in the composition is
About 0.001 to about 1% by weight, preferably about 0.01 to about 0.6% by weight, most preferably about 0.1 to 0.5% by weight
It is.
【0022】2種類の角質溶解剤が、本発明の組成物に
おいて効果的に用いられる。第一の種類を代表するもの
として、C7〜C30β−ヒドロキシカルボン酸およびそ
の塩類がある。このカテゴリーの例として、サリチル酸
およびそのアルカリ金属およびアンモニウム塩類があ
る。サリチル酸または塩の適量は、約0.001〜約1
0重量%、好ましくは約0.8〜約2.5重量%、最も
好ましくは約1〜1.5重量%であろう。[0022] Two types of keratolytic agents are effectively used in the compositions of the present invention. As representative of the first type, there is a C 7 -C 30 beta-hydroxycarboxylic acids and salts thereof. Examples of this category include salicylic acid and its alkali metal and ammonium salts. An appropriate amount of salicylic acid or salt is from about 0.001 to about 1
0%, preferably from about 0.8 to about 2.5%, most preferably from about 1 to 1.5% by weight.
【0023】角質溶解剤の第二の種類は、C2〜C25α
−ヒドロキシアルカン酸である。このグループの物質の
例として、グリコール酸、乳酸、α−ヒドロキシオクタ
ン酸およびその塩類がある。塩類はアルカリ金属、アン
モニウムおよびC1〜C20アルキルまたはアルカノール
アンモニウム対イオンから選んでよい。α−ヒドロキシ
アルカン酸のレベルは、約0.001〜約10重量%、
好ましくは約0.2〜1重量%、最も好ましくは約0.
4〜0.5重量%である。The second type of keratolytic agent is C 2 -C 25 α.
-Hydroxyalkanoic acid. Examples of this group of substances include glycolic acid, lactic acid, α-hydroxyoctanoic acid and salts thereof. Salts may be selected from alkali metal, ammonium and C 1 -C 20 alkyl or alkanolammonium counterions. the level of α-hydroxyalkanoic acid is from about 0.001 to about 10% by weight;
Preferably about 0.2-1% by weight, most preferably about 0,1%.
4 to 0.5% by weight.
【0024】本発明の組成物は水性または無水である。
好ましくは組成物は水性であり、特にW/OまたはO/
W型の水および油エマルジョンである。水が存在する場
合、その量は、約5〜約90%、好ましくは約35〜約
65%、最も好ましくは約40〜50重量%の量であ
る。The compositions of the present invention are aqueous or anhydrous.
Preferably the composition is aqueous, especially W / O or O /
W-type water and oil emulsion. When water is present, its amount is from about 5 to about 90%, preferably from about 35 to about 65%, most preferably from about 40 to 50% by weight.
【0025】水の他に、比較的揮発性の溶剤も本発明の
組成物の中に組み込んでよい。最も好ましいものはC1
〜C3アルカノールである。これらには、エチルアルコ
ール、メチルアルコール、およびイソプロピルアルコー
ルがある。一価アルカノールの量は、約5〜約50%、
好ましくは約15〜約40%、最も好ましくは約25〜
約35重量%である。In addition to water, relatively volatile solvents may be incorporated into the compositions of the present invention. Most preferred is C 1
~C is a 3 alkanol. These include ethyl alcohol, methyl alcohol, and isopropyl alcohol. The amount of monohydric alkanol is from about 5 to about 50%,
Preferably from about 15 to about 40%, most preferably from about 25 to
About 35% by weight.
【0026】シリコーン油および合成エステルの形態の
皮膚軟化物質も、本発明による組成物に組み込んでよ
い。皮膚軟化剤の量は、約0.1〜約30%、好ましく
は約1〜約20重量%の範囲のいずれかの量である。Emollients in the form of silicone oils and synthetic esters may also be incorporated into the compositions according to the invention. The amount of emollient may range anywhere from about 0.1 to about 30%, preferably from about 1 to about 20% by weight.
【0027】シリコーン油は揮発性と非揮発性の種類に
分けられる。ここで用いられる「揮発性」という用語
は、室温で測定し得る蒸気圧を有する物質をいう。揮発
性シリコーン油は、好ましくはシリコン原子を約3〜
9、好ましくは約4〜約5有する環状または直鎖状ポリ
ジメチルシロキサンから選ばれる。[0027] Silicone oils are divided into volatile and non-volatile types. The term "volatile" as used herein refers to a substance that has a measurable vapor pressure at room temperature. The volatile silicone oil preferably has about 3 to about 3 silicon atoms.
9, preferably from about 4 to about 5 cyclic or linear polydimethylsiloxanes.
【0028】直鎖状揮発性シリコーン物質は一般に、2
5℃での粘度が約5cSt以下である。一方、環状物質
は典型的には粘度が約10cSt以下である。The linear volatile silicone material is generally 2
The viscosity at 5 ° C. is about 5 cSt or less. On the other hand, cyclic materials typically have viscosities of less than about 10 cSt.
【0029】皮膚軟化物質として有用な非揮発性シリコ
ーン油には、ポリアルキルシロキサン、ポリアルキルア
リールシロキサン、ポリエーテルシロキサンコポリマー
がある。ここで有用な本質的に非揮発性のポリアルキル
シロキサンには、例えば25℃での粘度が約5〜約10
0,000cStのポリジメチルシロキサンがある。本
発明の組成物において有用な好ましい非揮発性皮膚軟化
剤は、25℃での粘度が約10〜約400cStのポリ
ジメチルシロキサンである。Non-volatile silicone oils useful as emollients include polyalkylsiloxanes, polyalkylarylsiloxanes, polyethersiloxane copolymers. Essentially non-volatile polyalkylsiloxanes useful herein include, for example, those having a viscosity at 25 ° C of from about 5 to about 10
There is a polydimethylsiloxane of 000 cSt. A preferred non-volatile emollient useful in the compositions of the present invention is a polydimethylsiloxane having a viscosity at 25C of about 10 to about 400 cSt.
【0030】エステル皮膚軟化剤としては下記のものが
ある: (1)炭素原子数10〜20を有する脂肪酸のアルケニ
ルまたはアルキルエステル。例として、イソノニルイソ
ナノノエート、オレイルミリステート、オレイルステア
レート、およびオレイルオレエートがある。Ester emollients include: (1) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples are isononyl isonanonoate, oleyl myristate, oleyl stearate, and oleyl oleate.
【0031】(2)エーテルエステル、例えばエトキシ
ル化脂肪族アルコールの脂肪酸エステル。(2) Ether esters such as fatty acid esters of ethoxylated fatty alcohols.
【0032】(3)多価アルコールエステル。エチレン
グリコールモノ−およびジ−脂肪酸エステル、ジエチレ
ングリコールモノ−およびジ−脂肪酸エステル、ポリエ
チレングリコール(200〜6000)モノ−およびジ
−脂肪酸エステル、プロピレングリコールモノ−および
ジ−脂肪酸エステル、ポリプロピレングリコール200
0モノオレエート、ポリプロピレングリコール2000
モノステアレート、エトキシル化プロピレングリコール
モノステアレート、グリセリルモノ−およびジ−脂肪酸
エステル、ポリグリセロールポリ−脂肪酸エステル、エ
トキシル化グリセリルモノステアレート、1,3−ブチ
レングリコールモノステアレート、1,3−ブチレング
リコールジステアレート、ポリオキシエチレンポリオー
ル脂肪酸エステル、ソルビタン脂肪酸エステル、および
ポリオキシエチレンソルビタン脂肪酸エステルが、多価
アルコールエステルとして満足すべきものである。(3) Polyhydric alcohol esters. Ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 200
0 monooleate, polypropylene glycol 2000
Monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty acid esters, ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene Glycol distearate, polyoxyethylene polyol fatty acid esters, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters.
【0033】(4)ワックスエステル、例えばみつろ
う、鯨ろう、ミリスチルミリステート、ステアリルステ
アレート。(4) Wax esters such as beeswax, spermaceti, myristyl myristate, and stearyl stearate.
【0034】(5)ステロールエステル、例えばコレス
テロール脂肪酸エステル。(5) Sterol esters such as cholesterol fatty acid esters.
【0035】最も好ましいエステルは、オクチルドデシ
ルネオペンタノエート(Elefac 1−205(R)
が入手できる)およびイソノニルイソノナノエートであ
る。The most preferred ester is octyldodecyl neopentanoate (Elefac 1-205® )
And isononyl isononanoate.
【0036】炭素原子数10〜30の脂肪酸も本発明の
組成物中に含めてよい。このカテゴリーの例として、ペ
ラルゴン酸、ラウリン酸、ミリスチン酸、パルミチン
酸、ステアリン酸、イソステアリン酸、ヒドロキシステ
アリン酸、オレイン酸、リノール酸、リシノール酸、ア
ラキン酸、ベヘン酸、およびエルカ酸がある。[0036] Fatty acids having 10 to 30 carbon atoms may also be included in the compositions of the present invention. Examples of this category include pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachiic, behenic, and erucic acids.
【0037】多価アルコール型の湿潤剤も本発明の組成
物中に含めてよい。湿潤剤は皮膚軟化剤の効果を高める
のを助け、皮膚のはがれを減らし、蓄積した鱗屑の除去
を促進し、皮膚の感触を改善する。典型的な多価アルコ
ールには、グリセロール、ポリアルキレングリコールが
あり、さらに好ましくはアルキレンポリオールおよびこ
れらの誘導体があり、例えば、プロピレングリコール、
ジプロピレングリコール、ポリプロピレングリコール、
ポリエチレングリコールおよびこれらの誘導体、ソルビ
トール、ヒドロキシプロピルソルビトール、ヘキシレン
グリコール、1,3−ブチレングリコール、1,2,6
−ヘキサントリオール、エトキシル化グリセロール、プ
ロポキシル化グリセロールおよびこれらの混合物があ
る。最高の結果を求めるならば、湿潤剤は好ましくはプ
ロピレングリコールである。湿潤剤の量は組成物の0.
5〜30重量%、好ましくは1〜15重量%の範囲のい
ずれかの量である。[0037] Wetting agents of the polyhydric alcohol type may also be included in the compositions of the present invention. Wetting agents help enhance the effect of emollients, reduce skin flaking, promote removal of accumulated scale, and improve skin feel. Typical polyhydric alcohols include glycerol, polyalkylene glycols, more preferably alkylene polyols and derivatives thereof, for example, propylene glycol,
Dipropylene glycol, polypropylene glycol,
Polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, 1,2,6
-Hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. For best results, the wetting agent is preferably propylene glycol. The amount of humectant is between 0.
Any amount in the range of 5 to 30% by weight, preferably 1 to 15% by weight.
【0038】総括して、水、溶剤、シリコーン、エステ
ル、脂肪酸、湿潤剤および/または増粘剤は、本発明の
組成物のための化粧品として許容し得るキャリヤーと考
えられる。キャリヤーの総量は、約1〜99.9重量
%、好ましくは約80〜99重量%である。In general, water, solvents, silicones, esters, fatty acids, humectants and / or thickeners are considered cosmetically acceptable carriers for the compositions of the present invention. The total amount of carrier is about 1-99.9% by weight, preferably about 80-99% by weight.
【0039】本発明の化粧品組成物はどんな形態でもよ
い。形態としては、ローション、クリーム、ロールオン
製剤、ムース、エアゾールスプレーおよびパッド塗布用
製剤がある。The cosmetic composition of the present invention may be in any form. Forms include lotions, creams, roll-on formulations, mousses, aerosol sprays and pad application formulations.
【0040】界面活性剤も本発明の化粧品組成物中に含
めてよい。界面活性剤の総濃度は、総組成物の約0.1
〜約40重量%、好ましくは約1〜約20重量%、最も
好ましくは約1〜約5重量%であろう。界面活性剤は、
アニオン性、非アニオン性、カチオン性、および両性活
性剤からなる群から選んでよい。特に好ましい非アニオ
ン性界面活性剤は、疎水性物質1モルあたり酸化エチレ
ンまたは酸化プロピレン約2〜約100モルで縮合され
たC10〜C20脂肪族アルコールまたは酸疎水性物質、酸
化アルキレン2〜20モルで縮合されたC2〜C10アル
キルフェノール、エチレングリコールのモノ−およびジ
−脂肪酸エステル、脂肪酸モノグリセリド、ソルビタ
ン、モノ−およびジ−C8〜C20脂肪酸、およびポリオ
キシエチレンソルビタンおよびその組み合わせである。
アルキルポリグリコシドおよび糖類脂肪酸アミド(例え
ばメチルグルコンアミド)も適切な非イオン性界面活性
剤である。[0040] Surfactants may also be included in the cosmetic compositions of the present invention. The total concentration of surfactant is about 0.1% of the total composition.
To about 40% by weight, preferably about 1 to about 20% by weight, most preferably about 1 to about 5% by weight. The surfactant is
It may be selected from the group consisting of anionic, non-anionic, cationic, and amphoteric surfactants. Particularly preferred non-anionic surfactants, C 10 -C 20 fatty alcohol or acid hydrophobe alkylene oxide 2 to 20 fused with a hydrophobic substance per mole of ethylene oxide or propylene oxide from about 2 to about 100 moles fused C 2 -C 10 alkyl phenols in a mole, of ethylene glycol mono - and di - fatty acid esters, fatty acid monoglycerides, sorbitan, mono - and di -C 8 -C 20 fatty acids, and polyoxyethylene sorbitan and combinations thereof .
Alkyl polyglycosides and saccharide fatty acid amides (eg, methyl gluconamide) are also suitable nonionic surfactants.
【0041】好ましいアニオン性界面活性剤には、ソー
プ、アルキルエーテルスルフェートおよびスルフォネー
ト、アルキルスルフェートおよびスルフォネート、アル
キルベンゼンスルフォネート、アルキルおよびジアルキ
ルスルフォスクシネート、C8〜C20アミルイセチオネ
ート、C8〜C20アルキルエーテルホスフェートおよび
これらの組み合わせがある。Preferred anionic surfactants include soaps, alkyl ether sulphates and sulphonates, alkyl sulphates and sulphonates, alkyl benzene sulphonates, alkyl and dialkyl sulphosuccinates, C 8 -C 20 amylisethionates, C 8 -C there are 20 alkyl ether phosphates and combinations thereof.
【0042】日焼け止め活性剤も本発明の組成中に含め
てよい。特に好ましい物質は、例えばParsol M
CXとして入手できるエチルヘキシルp−メトキシシン
ナメート、およびOxybenzoneとして知られて
いるベンゾフェノン−3である。無機日焼け止め活性
剤、例えば極微細二酸化チタン、ポリエチレンおよびそ
の他の様々なポリマーを用いてもよい。日焼け止め剤の
量は一般に、約0.1〜約30重量%、好ましくは約2
〜約20重量%、最も好ましくは約4〜約10重量%で
ある。[0042] Sunscreen actives may also be included in the compositions of the present invention. Particularly preferred substances are, for example, Parsol M
Ethylhexyl p-methoxycinnamate, available as CX, and benzophenone-3, also known as Oxybenzone. Inorganic sunscreen actives may be used, such as microfine titanium dioxide, polyethylene and various other polymers. The amount of sunscreen generally ranges from about 0.1 to about 30% by weight, preferably about 2%.
To about 20% by weight, most preferably about 4 to about 10% by weight.
【0043】防腐剤も、潜在的に有害な微生物の成長か
ら護るために、本発明の化粧品組成物に組み込まれるの
が望ましい。この発明の組成物に用いられる適切な常用
の防腐剤は、パラ−ヒドロキシ安息香酸のアルキルエス
テルである。さらに最近になって用いられるようになっ
たその他の防腐剤には、ヒダントイン誘導体、プロピオ
ネート塩、および様々な第四アンモニウム化合物があ
る。化粧品関係の化学者であれば、適切な防腐剤に精通
しており、防腐剤攻撃テストに耐え、かつ物質安定性を
与えるような防腐剤を日常的に選んでいる。特に好まし
い防腐剤は、フェノキシエタノール、メチルパラベン、
プロピルパラベン、イミダゾリジニルウレア、ナトリウ
ムデヒドロアセテートおよびベンジルアルコールであ
る。防腐剤は、この組成物の使用に配慮して、またこの
防腐剤と、エマルジョンに含まれるほかの成分との不相
溶性がありうることに配慮して選ばれるべきである。防
腐剤は、組成物の約0.01〜約2重量%の量で用いら
れるのが好ましい。Preservatives are also preferably incorporated into the cosmetic compositions of the present invention to protect against the growth of potentially harmful microorganisms. A suitable conventional preservative used in the compositions of this invention is an alkyl ester of para-hydroxybenzoic acid. Other preservatives that have recently come into use include hydantoin derivatives, propionate salts, and various quaternary ammonium compounds. Cosmetic chemists are familiar with the appropriate preservatives and routinely choose preservatives that withstand preservative attack tests and provide material stability. Particularly preferred preservatives are phenoxyethanol, methyl paraben,
Propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. Preservatives should be chosen with regard to the use of the composition and the potential for incompatibility of the preservative with other ingredients contained in the emulsion. Preservatives are preferably used in amounts of about 0.01 to about 2% by weight of the composition.
【0044】少量の添加成分もこの組成物中に存在して
よい。これらのものには、水不溶性ビタミン、例えばビ
タミンAパルミテート、ビタミンEアセテートおよびD
L−パンテノールがある。Small amounts of additional components may also be present in the composition. These include water-insoluble vitamins such as vitamin A palmitate, vitamin E acetate and D
There is L-panthenol.
【0045】もう1つの添加成分は酵素成分である。特
に好ましいものは、米国のBrooks Compan
yからBiocell SODという商品として入手で
きるスーパーオキシドジスムターゼである。Another additional component is an enzyme component. Particularly preferred are the Brooks Company of the United States.
y is a superoxide dismutase commercially available from Biocell SOD.
【0046】再生できる資源からの天然植物性物質も化
粧品組成物の成分として好ましいことが多い。例えば本
発明の化粧品組成物は、モンタナ州ミズーラのNurt
ure Inc.社からMicroat SFという商
標名で販売されている、オート麦に由来するβ−グルカ
ンを含んでいてもよい。Natural plant substances from renewable resources are also often preferred as components of cosmetic compositions. For example, the cosmetic composition of the present invention is available from Nurt of Missoula, Montana.
ure Inc. Β-glucan derived from oats, sold by the company under the trade name Microat SF.
【0047】着色剤、芳香剤、乳白剤、および研磨剤も
本発明の組成物に含まれうる。これらの物質は各々、約
0.05〜約5重量%、好ましくは0.1〜3重量%で
あってもよい。Colorants, fragrances, opacifiers, and abrasives can also be included in the compositions of the present invention. Each of these materials may be from about 0.05 to about 5% by weight, preferably 0.1 to 3% by weight.
【0048】[0048]
【実施例】下記実施例は本発明の実施態様をより詳細に
説明する。この実施例において、および添付特許請求の
範囲において記載されているすべての部、パーセント、
および割合は、別に表示のない限り重量を表す。The following examples illustrate embodiments of the present invention in more detail. In this example, and all parts, percentages,
And percentages represent weight unless otherwise indicated.
【0049】(実施例1)典型的な配合の本発明による
ホワイトニングクリームを下記に示す。EXAMPLE 1 A typical formulation of a whitening cream according to the present invention is shown below.
【0050】[0050]
【表1】 [Table 1]
【0051】(実施例2)実施例1のクリーム配合物の
安定性をテストした。但しDOW CORNING 2
00 (10 CST)の代わりにDOW CORNI
NG 200 (50 CST)を使用し、DOW C
ORNING 1402の代わりにDOWCORNIN
G 1401および1403を使用した。Example 2 The stability of the cream formulation of Example 1 was tested. However, DOW CORNING 2
00 (10 CST) instead of DOW CORNI
NG 200 (50 CST) and DOW C
DOWCORNIN instead of ORNING 1402
G 1401 and 1403 were used.
【0052】この製剤の試料は、室温、25℃、43
℃、50℃、および温度を変えて(4℃〜43℃で)調
製され、貯蔵された。A sample of this formulation was prepared at room temperature, 25 ° C., 43
Prepared and stored at varying degrees C, 50 C, and temperature (at 4 C to 43 C).
【0053】試料は、極端な温度条件下においても少な
くとも6週間安定状態を保つのが観察された。The sample was observed to remain stable for at least 6 weeks even under extreme temperature conditions.
【0054】前記の記載および実施例は本発明のうちの
選ばれた実施態様を示す。本発明から、当業者に様々な
変形例が示唆されるであろうが、それらも本発明の精神
の範囲に含まれる。The foregoing description and examples illustrate selected embodiments of the present invention. The present invention will suggest various modifications to those skilled in the art, which are also included in the spirit of the present invention.
Claims (7)
12〜C20脂肪酸ポリエチレングリコールエステルからな
る群から選ばれるエトキシル化アルコール、および(i
i)C7〜C12脂肪酸ペンダント鎖を有し、かつ実質的
にエトキシル化アルコールを含まない、グルコースをベ
ースとした非イオン性乳化剤、からなる群から選ばれる
乳化系約1〜約10重量%; (b)プラセンタエキス約0.5〜約10重量%; (c)化粧品として許容し得るキャリヤー約1〜約99
重量%、から成る化粧品組成物。(A) (i) C having 1 to 20 EO
Ethoxylated alcohols selected from the group consisting of 12 -C 20 fatty acid polyethylene glycol esters, and (i
i) has a C 7 -C 12 fatty acid pendent chains and is substantially free of ethoxylated alcohol, from about 1 to about 10 wt% emulsifying system selected glucose nonionic emulsifier-based, from the group consisting of (B) about 0.5 to about 10% by weight of placenta extract; (c) about 1 to about 99 cosmetically acceptable carriers.
% By weight of a cosmetic composition.
い、請求項1に記載の組成物。2. The composition of claim 1, wherein the pH range of the final composition is less than about 6.8.
化剤とが、約1.5:1〜約5:1の割合で存在する、
請求項1に記載の組成物。3. The method of claim 1, wherein the ethoxylated alcohol and the nonionic emulsifier are present in a ratio of about 1.5: 1 to about 5: 1.
The composition according to claim 1.
約1重量%を含む、請求項1に記載の組成物。4. A water-insoluble vitamin having a content of about 0.001 to about 0.001.
The composition of claim 1, comprising about 1% by weight.
タミンAパルミテート、およびDL−パンテノールから
なる群から選ばれる、請求項4に記載の組成物。5. The composition according to claim 4, wherein the vitamin is selected from the group consisting of vitamin E acetate, vitamin A palmitate, and DL-panthenol.
12〜C20脂肪酸ポリエチレングリコールエステルからな
る群から選ばれるエトキシル化アルコール、および(i
i)C7〜C12脂肪酸ペンダント鎖を有し、かつ実質的
にエトキシル化アルコールを含まない、グルコースをベ
ースとした非イオン性乳化剤、からなる群から選ばれる
乳化系約1〜約10重量%; (b)プラセンタエキス約0.5〜約10重量%;及び (c)化粧品として許容し得るキャリヤー1〜99重量
%、から成る化粧品組成物を皮膚に塗布し皮膚のホワイ
トニング効果を高める工程から成る、皮膚のホワイトニ
ング効果を高める方法。6. (a) (i) C having 1 to 20 EO
Ethoxylated alcohols selected from the group consisting of 12 -C 20 fatty acid polyethylene glycol esters, and (i
i) has a C 7 -C 12 fatty acid pendent chains and is substantially free of ethoxylated alcohol, from about 1 to about 10 wt% emulsifying system selected glucose nonionic emulsifier-based, from the group consisting of Applying a cosmetic composition comprising (b) about 0.5 to about 10% by weight of a placenta extract; and (c) 1 to 99% by weight of a cosmetically acceptable carrier to the skin to enhance the skin whitening effect. A method of enhancing the skin whitening effect.
20脂肪酸ポリエチレングリコールエステルからなる群か
ら選ばれるエトキシル化アルコール、および(ii)C
7〜C12脂肪酸ペンダント鎖を有し、かつ実質的にエト
キシル化アルコールを含まない、グルコースをベースと
した非イオン性乳化剤、から成る化粧品組成物であっ
て、(i):(ii)の比が約1.5:1〜約5:1で
ある組成物に用いられる乳化系。7. (i) C 12 -C having EO of 1-20
An ethoxylated alcohol selected from the group consisting of 20 fatty acid polyethylene glycol esters, and (ii) C
It has 7 -C 12 fatty acid pendent chains and is substantially free of ethoxylated alcohol, a cosmetic composition comprising glucose nonionic emulsifier based from the ratio of (i) :( ii) The emulsification system used in compositions wherein is from about 1.5: 1 to about 5: 1.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US834884 | 1992-02-11 | ||
US1817396P | 1996-05-23 | 1996-05-23 | |
US018173 | 1996-05-23 | ||
US83488497A | 1997-04-04 | 1997-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH1045530A true JPH1045530A (en) | 1998-02-17 |
Family
ID=26690816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9131114A Pending JPH1045530A (en) | 1996-05-23 | 1997-05-21 | Emulsion system containing small amount of ethoxylated emulsifier |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPH1045530A (en) |
KR (1) | KR19980079243A (en) |
NZ (1) | NZ314805A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016145169A (en) * | 2015-02-07 | 2016-08-12 | 尾池 哲郎 | Cream having property returning to aqueous solution |
-
1997
- 1997-05-13 NZ NZ314805A patent/NZ314805A/en unknown
- 1997-05-21 JP JP9131114A patent/JPH1045530A/en active Pending
- 1997-05-22 KR KR1019970019927A patent/KR19980079243A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016145169A (en) * | 2015-02-07 | 2016-08-12 | 尾池 哲郎 | Cream having property returning to aqueous solution |
Also Published As
Publication number | Publication date |
---|---|
KR19980079243A (en) | 1998-11-25 |
NZ314805A (en) | 1998-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5310556A (en) | Cosmetic composition | |
EP0841898B1 (en) | Topical compositions having improved skin feel | |
US5720961A (en) | Skin cleansing compositions | |
AU717000B2 (en) | Skin toning formulation | |
EP0841899B1 (en) | Compositions for topical delivery of active ingredients | |
US5980904A (en) | Skin whitening composition containing bearberry extract and a reducing agent | |
US5902591A (en) | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid | |
US5585104A (en) | Cleansing emulsions | |
US4737360A (en) | Skin care compositions | |
JP2768915B2 (en) | Rich cosmetic composition | |
CZ132998A3 (en) | Micro-structured cosmetic composition and process for preparing thereof | |
CA2238790C (en) | Stabilized cleansing composition with opacifier | |
JPH0714848B2 (en) | Cationic composition for skin | |
JP3780257B2 (en) | Dermal composition for oil and fat suppression | |
US5807561A (en) | Emulsifying system for a whitening cosmetic composition | |
KR100860895B1 (en) | Cosmetic cream cleaner | |
WO1998023257A1 (en) | Method for reducing skin oils and grease | |
JPH1045530A (en) | Emulsion system containing small amount of ethoxylated emulsifier | |
EP1369106B1 (en) | Emulsion composition | |
JPH11279023A (en) | Composition for external use | |
JPH1045526A (en) | Emulsion system for whitening cosmetic composition | |
JP2000191499A (en) | Moisturizing skin cosmetics | |
EP4442242A1 (en) | Cosmetic | |
CA1150153A (en) | Skin conditioning compositions | |
JPH08245333A (en) | Transparent two phase cosmetics composition |